Management of Aromatase Inhibitor-Induced Musculoskeletal Pain
Evidence-Based Treatment Recommendations
- The American Cancer Society/American Society of Clinical Oncology guidelines recommend acupuncture, physical activity, and physical therapy as the only interventions with demonstrated efficacy for aromatase inhibitor-associated musculoskeletal symptoms 1, 2
- Only acupuncture and exercise have demonstrated statistically significant improvement in aromatase inhibitor-associated symptoms 1, 2
- Intensive exercise regimens result in a 20% decrease in aromatase inhibitor-associated pain 1, 2
- Physical therapy, including stretching and other exercises, has been shown to be effective for managing musculoskeletal symptoms 1, 2
Prevalence and Challenges of Aromatase Inhibitor-Induced Pain
- Up to 50% of postmenopausal women receiving aromatase inhibitors report arthralgias and myalgias, with 20% experiencing pain severe enough to discontinue treatment 1, 2
- These symptoms are often not responsive to NSAIDs or acetaminophen 1, 2
- Poor adherence to aromatase inhibitor therapy increases breast cancer recurrence risk, making symptom management critical 1